{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:57:20Z","timestamp":1793228240274,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10771-1","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T10:00:19Z","timestamp":1751968819000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Interleukin-37 polymorphism (rs3811047) in Egyptian patients with ulcerative colitis"],"prefix":"10.1007","volume":"52","author":[{"given":"Amr A.","family":"Zahra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmeen A.","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Essam A.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shymaa E.","family":"Ayoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"issue":"5","key":"10771_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s40259-021-00496-5","volume":"35","author":"NJ Wyatt","year":"2021","unstructured":"Wyatt NJ, Speight RA, Stewart CJ, Kirby JA, Lamb CA (2021) Targeting leukocyte trafficking in inflammatory bowel disease. BioDrugs 35(5):473\u2013503. https:\/\/doi.org\/10.1007\/s40259-021-00496-5","journal-title":"BioDrugs"},{"issue":"10080","key":"10771_CR2","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","volume":"389","author":"R Ungaro","year":"2017","unstructured":"Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF (2017) Ulcerative colitis. Lancet (London England) 389(10080):1756\u20131770. https:\/\/doi.org\/10.1016\/S0140-6736(16)32126-2","journal-title":"Lancet (London England)"},{"key":"10771_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1146\/annurev-immunol-032414-112151","volume":"34","author":"JM Peloquin","year":"2016","unstructured":"Peloquin JM, Goel G, Villablanca EJ, Xavier RJ (2016) Mechanisms of pediatric inflammatory bowel disease. Annu Rev Immunol 34:31\u201364. https:\/\/doi.org\/10.1146\/annurev-immunol-032414-112151","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"10771_CR4","doi-asserted-by":"publisher","first-page":"e0228615","DOI":"10.1371\/journal.pone.0228615","volume":"15","author":"H Jodeleit","year":"2020","unstructured":"Jodeleit H, Milchram L, Soldo R, Beikircher G, Sch\u00f6nthaler S, Al-Amodi O, Wolf E, Beigel F, Weinh\u00e4usel A, Siebeck M, Gropp R (2020) Autoantibodies as diagnostic markers and potential drivers of inflammation in ulcerative colitis. PLoS ONE 15(2):e0228615. https:\/\/doi.org\/10.1371\/journal.pone.0228615","journal-title":"PLoS ONE"},{"key":"10771_CR5","doi-asserted-by":"publisher","first-page":"5918587","DOI":"10.1155\/2020\/5918587","volume":"2020","author":"C Liu","year":"2020","unstructured":"Liu C, Li Y, Chen Y, Huang S, Wang X, Luo S, Su Y, Zhou L, Luo X (2020) Baicalein restores the balance of Th17\/Treg cells via Aryl hydrocarbon receptor to attenuate colitis. Mediat Inflamm 2020:5918587","journal-title":"Mediat Inflamm"},{"issue":"5","key":"10771_CR6","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1002\/eji.201545828","volume":"46","author":"CA Dinarello","year":"2016","unstructured":"Dinarello CA, Nold-Petry C, Nold M, Fujita M, Li S, Kim S, Bufler P (2016) Suppression of innate inflammation and immunity by interleukin\u201037. Eur J Immunol 46(5):1067\u20131081","journal-title":"Eur J Immunol"},{"issue":"4","key":"10771_CR7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.32607\/20758251-2019-11-4-54-64","volume":"11","author":"IP Shilovskiy","year":"2019","unstructured":"Shilovskiy IP, Dyneva ME, Kurbacheva OM, Kudlay DA, Khaitov MR (2019) The role of Interleukin-37 in the pathogenesis of allergic diseases. Acta Naturae 11(4):54\u201364","journal-title":"Acta Naturae"},{"key":"10771_CR8","doi-asserted-by":"publisher","first-page":"1261666","DOI":"10.3389\/fimmu.2023.1261666","volume":"14","author":"L Kr\u00f6hn","year":"2023","unstructured":"Kr\u00f6hn L, Azabdaftari A, Heuberger J, Hudert C, Zilbauer M, Breiderhoff T, Bufler P (2023) Modulation of intestinal IL-37 expression and its impact on the epithelial innate immune response and barrier integrity. Front Immunol 14:1261666. https:\/\/doi.org\/10.3389\/fimmu.2023.1261666","journal-title":"Front Immunol"},{"key":"10771_CR9","doi-asserted-by":"crossref","unstructured":"Wu K, Kong F, Zhang J, Tang Y, Chen Y, Chao L, Nie L, Huang Z (2023) Recent progress in Single-Nucleotide polymorphism biosensors. Biosensors 13(9)","DOI":"10.3390\/bios13090864"},{"key":"10771_CR10","doi-asserted-by":"crossref","unstructured":"Nesreen M, Aboraia a, Aliaa A, Ali a, Amal T (March 2025) Abdel-Rahman b, Omayma O. Abdelaleem serum interleukin-37 and its gene polymorphism (rs3811047) in Egyptian patients with alopecia areata gene reports. 38:102122","DOI":"10.1016\/j.genrep.2024.102122"},{"key":"10771_CR11","unstructured":"Chen C, Pan XUS, F., XU J (2011) Study of the interleukin-1F7 gene single nucleotide polymorphism in patients with ankylosing spondylitis. Chin J Rheumatol, 546\u2013549"},{"issue":"3","key":"10771_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1530\/JME-15-0144","volume":"55","author":"N Yan","year":"2015","unstructured":"Yan N, Meng S, Song R-H, Qin Q, Wang X, Yao Q, Jiang Y, Jiang W, Shi L, Xu J, Zhang J (2015) Polymorphism of IL37 gene as a protective factor for autoimmune thyroid disease. J Mol Endocrinol 55(3):209\u2013218","journal-title":"J Mol Endocrinol"},{"key":"10771_CR13","doi-asserted-by":"publisher","first-page":"35802","DOI":"10.1038\/srep35802","volume":"6","author":"H Tan","year":"2016","unstructured":"Tan H, Deng B, Yu H, Yang Y, Ding L, Zhang Q, Qin J, Kijlstra A, Chen R, Yang P (2016) Genetic analysis of innate immunity in behcet\u2019s disease identifies an association with IL-37 and IL-18RAP. Sci Rep 6:35802","journal-title":"Sci Rep"},{"key":"10771_CR14","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.crohns.2013.06.001","volume":"7","author":"F Magro","year":"2013","unstructured":"Magro F, Langner C, Driessen A, Ensari A, Geboes K, Mantzaris GJ et al (2013) European consensus on the histopathology of inflammatory bowel disease. J Crohn\u2019s Colitis 7:827\u2013851","journal-title":"J Crohn\u2019s Colitis"},{"issue":"10401","key":"10771_CR15","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","volume":"402","author":"C Le Berre","year":"2023","unstructured":"Le Berre C, Honap S, Peyrin-Biroulet L (2023) Ulcerative colitis. Lancet (London England) 402(10401):571\u2013584. https:\/\/doi.org\/10.1016\/S0140-6736(23)00966-2","journal-title":"Lancet (London England)"},{"key":"10771_CR16","doi-asserted-by":"publisher","unstructured":"Preda C-M, Istr\u0103tescu D (2022) Etiology of Ulcerative Colitis. In P. Pal (Ed.), Ulcerative Colitis. IntechOpen. https:\/\/doi.org\/10.5772\/intechopen.106842","DOI":"10.5772\/intechopen.106842"},{"issue":"1","key":"10771_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/jbcpp-2018-0036","volume":"30","author":"N Tatiya-Aphiradee","year":"2018","unstructured":"Tatiya-Aphiradee N, Chatuphonprasert W, Jarukamjorn K (2018) Immune response and inflammatory pathway of ulcerative colitis. J Basic Clin Physiol Pharmacol 30(1):1\u201310. https:\/\/doi.org\/10.1515\/jbcpp-2018-0036","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"10771_CR18","doi-asserted-by":"publisher","first-page":"104835","DOI":"10.1016\/j.phrs.2020.104835","volume":"158","author":"M Leppkes","year":"2020","unstructured":"Leppkes M, Neurath MF (2020) Cytokines in inflammatory bowel diseases\u2013update 2020. Pharmacol Res 158:104835","journal-title":"Pharmacol Res"},{"issue":"3","key":"10771_CR19","doi-asserted-by":"publisher","first-page":"165","DOI":"10.22034\/iji.2018.39386","volume":"15","author":"X Wang","year":"2018","unstructured":"Wang X, Xu K, Chen S, Li Y, Li M (2018) Role of Interleukin-37 in inflammatory and autoimmune diseases. Iran J Immunol 15(3):165\u2013174. https:\/\/doi.org\/10.22034\/iji.2018.39386","journal-title":"Iran J Immunol"},{"key":"10771_CR20","doi-asserted-by":"publisher","unstructured":"Conti P, Stellin L, Caraffa A, Gallenga CE, Ross R, Kritas SK, Frydas I, Younes A, Di Emidio P, Ronconi G (2020) Advances in mast cell activation by IL-1 and IL-33 in sj\u00f6gren\u2019s syndrome: promising inhibitory effect of IL-37. Int J Mol Sci 21(12). https:\/\/doi.org\/10.3390\/ijms21124297","DOI":"10.3390\/ijms21124297"},{"issue":"3","key":"10771_CR21","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1055\/a-2153-8836","volume":"43","author":"B Jiang","year":"2023","unstructured":"Jiang B, Zhou Y, Liu Y, He S, Liao B, Peng T, Yao L, Qi L (2023) Research progress on the role and mechanism of IL-37 in liver diseases. Semin Liver Dis 43(3):336\u2013350. https:\/\/doi.org\/10.1055\/a-2153-8836","journal-title":"Semin Liver Dis"},{"key":"10771_CR22","doi-asserted-by":"publisher","first-page":"696605","DOI":"10.3389\/fimmu.2021.696605","volume":"12","author":"Z Su","year":"2021","unstructured":"Su Z, Tao X (2021) Current Understanding of IL-37 in human health and disease. Front Immunol 12:696605. https:\/\/doi.org\/10.3389\/fimmu.2021.696605","journal-title":"Front Immunol"},{"issue":"2","key":"10771_CR23","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1097\/MPG.0000000000000387","volume":"59","author":"S Weidlich","year":"2014","unstructured":"Weidlich S, Bulau A-M, Schwerd T, Althans J, Kappler R, Koletzko S, Mayr D, Bufler P (2014) Intestinal expression of the anti-inflammatory interleukin-1 homolog IL-37 in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 59(2):e18\u201326","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10771_CR24","doi-asserted-by":"publisher","first-page":"1431495","DOI":"10.3389\/fimmu.2024.1431495","volume":"15","author":"Q Wang","year":"2024","unstructured":"Wang Q, Zhang G, An C, Hambly BD, Bao S (2024) The role of IL-37 in Gastrointestinal diseases. Front Immunol 15:1431495. https:\/\/doi.org\/10.3389\/fimmu.2024.1431495","journal-title":"Front Immunol"},{"key":"10771_CR25","doi-asserted-by":"crossref","unstructured":"Li Y, Wang Y, Liu Y, Wang Y, Zuo X, Li Y, Lu X (2014) The possible role of the novel cytokines il-35 and il-37 in inflammatory bowel disease. Mediators of Inflammation, 2014","DOI":"10.1155\/2014\/136329"},{"key":"10771_CR26","doi-asserted-by":"crossref","unstructured":"Zhang ZZ, Zhang Y, He T, Sweeney CL, Baris S, Karakoc-Aydiner E, Yao Y, Ertem D, Matthews HF, Gonzaga-Jauregui C, Malech HL, Su HC, Ozen A, Smith KGC, Lenardo MJ (2021) Homozygous IL37 mutation associated with infantile inflammatory bowel disease. Proc Natl Acad Sci USA, 118(10)","DOI":"10.1073\/pnas.2009217118"},{"key":"10771_CR27","doi-asserted-by":"crossref","unstructured":"Ger\u00e7eker E, Cerrah S (2023) Platelet, mean platelet volume and platelet distribution width levels might be promising markers for the prediction of disease severity, mucosal healing, and steroid dependence in patients with ulcerative colitis. Cureus, 15(1)","DOI":"10.7759\/cureus.33286"},{"issue":"4","key":"10771_CR28","first-page":"15","volume":"22","author":"CA L\u00f3pez-Bernal","year":"2022","unstructured":"L\u00f3pez-Bernal CA, Garc\u00eda-Galicia A, Quezada-Ju\u00e1rez FJ, Rojas-Illanes MF, Rubio-Mart\u00ednez B, Montiel-Jarqu\u00edn \u00c1J, Jim\u00e9nez-Luna I, Loria-Castellanos J (2022) Clinical, biochemical, endoscopic, and histopathological evaluation of biological treatment in ulcerative colitis. Revista De La Facultad De Med Humana 22(4):15","journal-title":"Revista De La Facultad De Med Humana"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10771-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10771-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10771-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T04:26:05Z","timestamp":1766895965000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10771-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10771"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10771-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board (IRB) of Fayoum University\u2019s Faculty of Medicine granted ethical approval for the study protocol (Ethical Approval No. M695). All participants provided written informed consent before enrollment and sample collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"685"}}